These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. International consensus for advanced bladder cancer: an opportunity between the lines. Murthy V Ann Oncol; 2019 Nov; 30(11):1688-1690. PubMed ID: 31750878 [No Abstract] [Full Text] [Related]
3. Bladder cancer. Clark PE; Agarwal N; Biagioli MC; Eisenberger MA; Greenberg RE; Herr HW; Inman BA; Kuban DA; Kuzel TM; Lele SM; Michalski J; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Porter MP; Richie JP; Sexton WJ; Shipley WU; Small EJ; Spiess PE; Trump DL; Wile G; Wilson TG; Dwyer M; Ho M; J Natl Compr Canc Netw; 2013 Apr; 11(4):446-75. PubMed ID: 23584347 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit? Niegisch G; Lorch A; Droller MJ; Lavery HJ; Stensland KD; Albers P Eur Urol; 2013 Sep; 64(3):355-7. PubMed ID: 23773558 [TBL] [Abstract][Full Text] [Related]
5. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY; Ann Oncol; 2018 Oct; 29(Suppl 4):iv51-iv67. PubMed ID: 29846498 [No Abstract] [Full Text] [Related]
6. Can bladder preservation therapy come to the center stage? Inamoto T; Ibuki N; Komura K; Juri H; Yamamoto K; Yamamoto K; Fujita K; Nonomura N; Narumi Y; Azuma H Int J Urol; 2018 Feb; 25(2):134-140. PubMed ID: 29171098 [TBL] [Abstract][Full Text] [Related]
11. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Casali PG; Bielack S; Abecassis N; Aro HT; Bauer S; Biagini R; Bonvalot S; Boukovinas I; Bovee JVMG; Brennan B; Brodowicz T; Broto JM; Brugières L; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Dhooge C; Eriksson M; Fagioli F; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gaspar N; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hecker-Nolting S; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kager L; Kasper B; Kopeckova K; Krákorová DA; Ladenstein R; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Morland B; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Strauss SJ; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY; Ann Oncol; 2018 Oct; 29(Suppl 4):iv79-iv95. PubMed ID: 30285218 [No Abstract] [Full Text] [Related]
12. Adjuvant Chemotherapy Is More Suitable Than Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Patients Treated With Radical Chemoradiotherapy. Joseph N; Choudhury A Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):614-6. PubMed ID: 27681756 [No Abstract] [Full Text] [Related]
16. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T; Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609 [TBL] [Abstract][Full Text] [Related]
17. Evolving Treatment Paradigm in the Treatment of Locally Advanced Rectal Cancer. Smith CA; Kachnic LA J Natl Compr Canc Netw; 2018 Jul; 16(7):909-915. PubMed ID: 30006431 [TBL] [Abstract][Full Text] [Related]
18. SEOM clinical guidelines for the treatment of invasive bladder cancer. Morales R; Font A; Carles J; Isla D Clin Transl Oncol; 2011 Aug; 13(8):552-9. PubMed ID: 21821489 [TBL] [Abstract][Full Text] [Related]
19. Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey. Choo SH; Nishiyama H; Kitamura H; Chen CH; Pu YS; Lee HL; Jeong BC; Kim SI Int J Urol; 2019 Dec; 26(12):1121-1127. PubMed ID: 31512280 [TBL] [Abstract][Full Text] [Related]
20. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. Hall MC; Chang SS; Dalbagni G; Pruthi RS; Seigne JD; Skinner EC; Wolf JS; Schellhammer PF J Urol; 2007 Dec; 178(6):2314-30. PubMed ID: 17993339 [No Abstract] [Full Text] [Related] [Next] [New Search]